Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.
暂无分享，去创建一个
J. Wu | J. Young | Zheng Zhou | Zhiheng Xu | A. Mayweg | Sheng Zhong | Jianxun Xie | Guozhi Tang | Weixing Zhang | Taishan Hu | Zongxing Qiu | Xianfeng Lin | Hongxia Qiu | Yuxia Zhang | N. Qin | Hong C Shen | Guolong Wu | Yimin Hu | K. Sun | Jim Z Wu | Wei Zhu | G. Ottaviani | Haixia Liu | Lu Gao | Yue Wang | S. Yan | F. Shen | Mengwei Huang | Shuang Ren | Lina Zhu | Lei Guo | Guang-de Yang | Xue Zhou | Xiaoyue Wu | Buelent Koçer | Buyu Kou | Houguang Shi | Mingwei Zhou | Yi Mao | Yi Zhang | Yuan Zhou | Zhisen Zhang | X. Tian | Liping Shi